NCT02689310

Brief Summary

The investigators hypothesize that the use of leptospermum scoparium honey as a type of dressing and/or debridement agent on stage III or IV pressure ulcers has an increased efficacy and safety compared to the current treatment protocol that includes the use of hydrogel/Vaseline, collagenase, and silver alginate dressings as the standard of care. Utilizing a non-inferiority trial, it is expected that the use of leptospermum scoparium as a treatment for Stage III and Stage IV pressure ulcers will not be inferior to the comparison treatment of standard of care wound dressings. Moreover, this research design will enable the research team to determine if the honey based dressings are equivalent to or superior to the comparison treatment. Therefore, the investigators specific study objectives are as follows:

  1. 1.Primary Objectives: Determine if the use of honey as an alternative treatment will reduce site inflammation/irritation and pain associated with pressure ulcers compared to the standard treatment options. Specifically, the investigators will monitor patient PUSH scores, Braden Risk Scale scores, granulation and/or epithelial tissue progression, length of time to heal, patient pain assessments via the Wong Baker Face or Numeric Scale, wound odors, and incidence of adverse events (measured by allergies, stinging sensations, bacterial infections that warrant antibiotic intervention, etc.).
  2. 2.Secondary Objective: Patients in the honey treatment group will have lower costs per healed ulcer than patients in the standard collagenase treatment group.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2018

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 8, 2016

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 23, 2016

Completed
2 years until next milestone

Study Start

First participant enrolled

March 1, 2018

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
Last Updated

April 18, 2018

Status Verified

April 1, 2018

Enrollment Period

1 month

First QC Date

February 8, 2016

Last Update Submit

April 16, 2018

Conditions

Keywords

Wound CareMedical Grade HoneyPressure Ulcers

Outcome Measures

Primary Outcomes (7)

  • Total Score on the Pressure Ulcer Scale for Healing (PUSH) Scale

    Developed by the National Pressure Ulcer Advisory Panel (NPUAP) as a quick and reliable tool to monitor the change in pressure ulcer status over time and has been incorporated as a standard assessment tool in acute care settings.

    6 weeks

  • Odor (scored as no odor, odor on dressing change, odor all the time)

    Observed by staff and patient, will be scored as no odor, odor on dressing change, odor all the time.

    6 weeks

  • Incidence of adverse events

    6 weeks

  • Braden Scale assessment

    6 weeks

  • Irritation

    Presence or absence of irritation as determined by clinical observation

    6 weeks

  • Inflammation

    Presence or absence of irritation as determined by clinical observation

    6 weeks

  • Pain

    Pain in and around pressure ulcer assessed by tenderness to the touch by clinician (recorded as present or absent)

    6 weeks

Secondary Outcomes (1)

  • Costs treated per ulcer

    1 year

Study Arms (4)

Standard Care - Stage III Pressure Ulcers

OTHER

Patients with a stage III pressure ulcer who are randomized into this arm will be given standard treatment (hydrogel, collegense, and silver alginate dressings).

Other: Standard of Care Treatment

Honey Treatment - Stage III Pressure Ulcers

EXPERIMENTAL

Patients with a stage III pressure ulcer who are randomized into this treatment arm will be given leptospermum scoparium honey dressings for treatment of their wound.

Other: Leptospermum scoparium honey

Standard Care - Stage IV Pressure Ulcers

OTHER

Patients with a stage IV pressure ulcer who are randomized into this arm will be given standard treatment (hydrogel, collegense, and silver alginate dressings).

Other: Standard of Care Treatment

Honey Treatment - Stage IV Pressure Ulcers

EXPERIMENTAL

Patients with a stage IV pressure ulcer who are randomized into this treatment arm will be given leptospermum scoparium honey dressings for treatment of their wound.

Other: Leptospermum scoparium honey

Interventions

No information available- PI left- study being withdrawn.

Honey Treatment - Stage III Pressure UlcersHoney Treatment - Stage IV Pressure Ulcers

No information available- PI left- study being withdrawn.

Standard Care - Stage III Pressure UlcersStandard Care - Stage IV Pressure Ulcers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult (18 years old and older)
  • Newly admitted patients with a diagnosis Pressure Ulcers (Stages III and IV) or patients who develop nosocomial pressure ulcers Stage III and Stage IV
  • Ability to provide written informed consent (either patient or legal personal representative)

You may not qualify if:

  • Patient/representative refuses to give written informed consent
  • Patient diagnosed with terminal illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NYC Health + Hospitals/Coney Island

Brooklyn, New York, 11235, United States

Location

MeSH Terms

Conditions

Pressure Ulcer

Condition Hierarchy (Ancestors)

Skin UlcerSkin DiseasesSkin and Connective Tissue Diseases
0

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 8, 2016

First Posted

February 23, 2016

Study Start

March 1, 2018

Primary Completion

April 1, 2018

Study Completion

April 1, 2018

Last Updated

April 18, 2018

Record last verified: 2018-04

Locations